申请人:Ciba-Geigy Corporation
公开号:US04246269A1
公开(公告)日:1981-01-20
The present invention provides new derivatives of perhydro-aza-heterocycles of the formula ##STR1## in which X is the oxo radical or hydrogen and the radical OR.sub.1, in which R.sub.1 is hydrogen or a substituted or unsubstituted aliphatic hydrocarbon radical, a substituted or unsubstituted araliphatic hydrocarbon radical or a substituted or unsubstituted aromatic hydrocarbon radical or an acyl radical, R.sub.2 is hydrogen or a substituted or unsubstituted aliphatic hydrocarbon radical, Y is oxygen or sulphur, n.sub.1 and n.sub.2 each are values of 1 to 3, n.sub.1 +n.sub.2 being at most four, and Ar is a substituted or unsubstituted aromatic hydrocarbon radical, and the acid addition salts, in particular the pharmaceutically acceptable acid addition salts thereof. These new substances possess valuable pharmacological properties, in particular antidepressant activity, and can be used for the treatment of mental depressions. Specific embodiments are trans- and cis-3-hydroxy-4-(3,4-dimethyl-phenoxy)-piperidine, trans- and cis-3-hydroxy-4-(2,3-dimethyl-phenoxy)-piperidine, their 1-methyl derivatives and the pharmaceutically acceptable salts of these substances.
本发明提供了新的过氢化-氮杂杂环衍生物的衍生物,其化学式为##STR1##
其中X是氧代基或氢,基OR.sub.1是氢或取代或未取代的脂肪烃基、取代或未取代的芳杂烃基或取代或未取代的芳香烃基或酰基,R.sub.2是氢或取代或未取代的脂肪烃基,Y是氧或硫,n.sub.1和n.sub.2分别是1到3的值,n.sub.1 + n.sub.2最多为4,Ar是取代或未取代的芳香烃基,以及其酸加成盐,特别是其药用可接受的酸加成盐。这些新物质具有有价值的药理学特性,特别是抗抑郁活性,可用于治疗精神抑郁症。具体实施例包括顺式和反式3-羟基-4-(3,4-二甲基-苯氧基)-哌啶、顺式和反式3-羟基-4-(2,3-二甲基-苯氧基)-哌啶、它们的1-甲基衍生物和这些物质的药用可接受的盐。